CD8A and neoplasm: HAS is typically characterized as an immunologically “cold” tumor, featuring diminished infiltration of CD8+ T cells, an abundance of regulatory T cells (Tregs) and M2-type macrophages, low PD-L1 expression, and a low tumor mutational burden (TMB).